Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Kessler

Hand Surgery Washington, DC Medical Doctor

NPI 1982926523 CMS profile 846802

3800 Reservoir Rd Nw, Georgetown University Hospital/Orthopaedic Surgery, Washington, DC 20007

Open in the dashboard

General payments

$85,496

103 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$811

1 holding reported · through program year 2025

Through program year 2025, Michael Kessler of Washington, DC is reported in the CMS Open Payments database as having received $85,496 across 103 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $811 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $39,284 21
2024 General $8,639 12
2023 General $7,769 4
2022 General $11,546 11
2021 General $1,844 4
2020 General $3,928 19
2019 General $12,486 32
2025 Ownership $811 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Kessler
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Michael Kessler were reported at $39,284. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Michael Kessler Hand Surgery median Middle half National median
2019 $12,486 $383 $106–$1,905 $163
2020 $3,928 $172 $51–$1,268 $114
2021 $1,844 $263 $71–$1,591 $132
2022 $11,546 $336 $87–$1,938 $149
2023 $7,769 $233 $81–$1,114 $160
2024 $8,639 $258 $88–$1,203 $164
2025 $39,284 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medartis Inc. $53,703 13 payments
  2. Zimmer Biomet Holdings, Inc. $9,556 19 payments
  3. Stryker Corporation $5,030 14 payments
  4. Exactech, Inc. $4,031 3 payments
  5. Wright Medical Technology, Inc. $3,750 4 payments
  6. Oxford Performance Materials, Inc. $2,483 2 payments
  7. Supreme Orthopedic Systems, LLC $1,863 11 payments
  8. Newclip USA LLC $1,800 1 payment
  9. Arthrex, Inc. $1,694 13 payments
  10. Osteomed LLC $188 2 payments
  11. Other $1,399 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $69,850 18 payments
  2. Food and Beverage $7,306 63 payments
  3. Travel and Lodging $3,835 18 payments
  4. Royalty or License $3,755 1 payment
  5. Education $749 3 payments
Products named General payments · program years 2019–2025
  1. APTUS Ortho $29,165 3 payments
  2. APTUS Ortho $19,178 8 payments
  3. Alps Plates and Instruments $7,500 3 payments
  4. APTUS Ortho $5,360 2 payments
  5. TRULIANT $3,755 1 payment
  6. CARTIVA $3,750 4 payments
  7. CARTIVA SYNTHETIC CARTILAGE IMPLANT $3,500 2 payments
  8. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $334 2 payments
  9. OPTETRAK $276 2 payments
  10. SERRATO $270 2 payments
  11. Other $3,839 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

16

Median for Hand Surgery: 118

Drug cost

$62

Median for Hand Surgery: $615

Branded share of claims

0%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 16 $62

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 108 billing codes

Paid by Medicare

$190,327

Medicare's payments for the services billed

Medicare patients

406

Average age 72

Services billed

1,367

266 women, 140 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 68%
High blood pressure 64%
Diabetes 25%
Ischemic heart disease 22%
Osteoporosis 19%
Depression 17%
Cancer 16%
Chronic kidney disease 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record